What does the CTNM options chain show right now?

As of May 15, 2026, Contineum Therapeutics, Inc. Class A Common Stock (CTNM) has 337 contracts outstanding and 17 traded today, with ATM IV of 140.2%. The full chain spans every listed strike and expiration with bid/ask, Greeks, volume, and open interest per contract.

What expirations are available for CTNM options?

The nearest expiration is 34 days out, followed by 63 days. Listed expirations typically extend monthly with weeklies between, plus LEAPS one to two years out for liquid names.

How tight are CTNM options bid/ask spreads?

Average bid/ask spread across the chain is 89.50%. Wider spreads warrant conservative sizing; mid-market fills are unreliable for retail-size orders.

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Options Chain

The options chain displays all available contracts with real-time quotes, Greeks, volume, and open interest for each strike and expiration. It is the primary tool for options trade selection.

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $529.0M, listed on NASDAQ, employing roughly 41 people, carrying a beta of 0.89 to the broader market. Contineum Therapeutics, Inc. Led by Carmine N. Stengone, public since 2024-04-05.

Snapshot as of May 15, 2026.

Spot Price: $13.72
Total OI: 337
Total Volume: 17
Front Expiration: 34 days
Second Expiration: 63 days
ATM IV: 140.2%
Avg Bid/Ask Spread: 89.50%

As of May 15, 2026, Contineum Therapeutics, Inc. Class A Common Stock (CTNM) has 337 open contracts and 17 contracts traded. The nearest expiration is 34 days out, followed by 63 days. ATM implied volatility is 140.2%. Average bid/ask spread across the chain is 89.50%: wider spreads, size positions conservatively. The options chain aggregates every listed strike and expiration, letting traders evaluate skew, term structure, and liquidity in a single view.

How CTNM options chain Data Feeds Strategy Selection

Strategy selection on Contineum Therapeutics, Inc. Class A Common Stock options does not derive from any single metric in isolation. The options chain view above sits inside a broader read: ATM IV currently sits at 140.2% and dealer gamma exposure is positive, so dealer hedging is mechanically mean-reverting. Combine the options chain data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.

Learn how the options chain is reported and how to read the data →

Frequently asked CTNM options chain questions

What does the CTNM options chain show right now?: As of May 15, 2026, Contineum Therapeutics, Inc. Class A Common Stock (CTNM) has 337 contracts outstanding and 17 traded today, with ATM IV of 140.2%. The full chain spans every listed strike and expiration with bid/ask, Greeks, volume, and open interest per contract.
What expirations are available for CTNM options?: The nearest expiration is 34 days out, followed by 63 days. Listed expirations typically extend monthly with weeklies between, plus LEAPS one to two years out for liquid names.
How tight are CTNM options bid/ask spreads?: Average bid/ask spread across the chain is 89.50%. Wider spreads warrant conservative sizing; mid-market fills are unreliable for retail-size orders.